PERP B — Perpetua Medical AB (publ) Income Statement
0.000.00%
- SEK21.70m
- SEK19.32m
- SEK6.94m
- 13
- 13
- 65
- 17
Annual income statement for Perpetua Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.9 | 8.82 | 10.1 | 9.94 | 6.94 |
Cost of Revenue | |||||
Gross Profit | -5.88 | -2.36 | -3.72 | -3.46 | -3.08 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.4 | 22.5 | 29.2 | 28.4 | 9.36 |
Operating Profit | -14.5 | -13.7 | -19.1 | -18.5 | -2.42 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -14.6 | -13.7 | -19.2 | -18.3 | -2.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.6 | -13.7 | -19.2 | -18.3 | -2.38 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -14.6 | -13.7 | -19.2 | -18.3 | -2.47 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.6 | -13.7 | -19.2 | -18.3 | -2.47 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -21.9 | -17.1 | -22.3 | -10.6 | -0.517 |
Dividends per Share |